company background image
HOLX logo

Hologic WBAG:HOLX Stock Report

Last Price

€73.50

Market Cap

€17.0b

7D

0.7%

1Y

12.4%

Updated

11 Oct, 2024

Data

Company Financials +

HOLX Stock Overview

Develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment.

HOLX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Hologic, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hologic
Historical stock prices
Current Share PriceUS$73.50
52 Week HighUS$77.00
52 Week LowUS$60.90
Beta0.98
11 Month Change0.68%
3 Month Change3.52%
1 Year Change12.39%
33 Year Change21.33%
5 Year Change63.33%
Change since IPO91.34%

Recent News & Updates

Recent updates

Shareholder Returns

HOLXAT Medical EquipmentAT Market
7D0.7%0.4%0.3%
1Y12.4%22.9%5.6%

Return vs Industry: HOLX underperformed the Austrian Medical Equipment industry which returned 20.5% over the past year.

Return vs Market: HOLX exceeded the Austrian Market which returned 5.6% over the past year.

Price Volatility

Is HOLX's price volatile compared to industry and market?
HOLX volatility
HOLX Average Weekly Movement2.3%
Medical Equipment Industry Average Movement5.6%
Market Average Movement3.5%
10% most volatile stocks in AT Market6.1%
10% least volatile stocks in AT Market1.9%

Stable Share Price: HOLX has not had significant price volatility in the past 3 months compared to the Austrian market.

Volatility Over Time: HOLX's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19856,990Steve MacMillanwww.hologic.com

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
HOLX fundamental statistics
Market cap€16.98b
Earnings (TTM)€641.52m
Revenue (TTM)€3.65b

26.4x

P/E Ratio

4.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HOLX income statement (TTM)
RevenueUS$3.99b
Cost of RevenueUS$1.57b
Gross ProfitUS$2.42b
Other ExpensesUS$1.71b
EarningsUS$701.50m

Last Reported Earnings

Jun 29, 2024

Next Earnings Date

Nov 04, 2024

Earnings per share (EPS)3.02
Gross Margin60.58%
Net Profit Margin17.59%
Debt/Equity Ratio51.4%

How did HOLX perform over the long term?

See historical performance and comparison